Robust Oligonucleotide Molecular Weight Confirmation by LC-MS

Webinar Date/Time: Airing 1: Tuesday, June 25th, 2024 at 8am PDT | 11am EDT | 4pm BST | 5pm CEST Airing 2: Tuesday, June 25th, 2024 at 11am PDT | 2pm EDT | 7pm BST | 8pm CEST Airing 3: Wednesday, June 26th, 2024 at 11am JST | 7pm PDT | 9pm CST

How to Achieve Confident Oligonucleotide Characterization and Purification

Discover how to accurately analyze purity and impurities, determine sequences, and more with next-generation technologies from Agilent.

Upgrading to Zero-Waste Raw Material Identification with the Agilent Vaya

Reaching sustainability and efficiency goals simultaneously is possible in RMID, a regulatory-enforced part of (bio)pharmaceutical drug manufacturing.

Best Practices for Analysis of In Vitro Transcribed (IVT) mRNA Using the Agilent Fragment Analyzer systems

This technical overview discusses best handling practices for IVT mRNA and analysis with the Fragment Analyzer systems, including sample handling and quantification tips.

Oligo Workflow Resource Guide

End-to-End Workflow Solutions for Oligonucleotide Analysis - From research discovery to production QA/QC

End-to-End Oligonucleotide Solutions

This short video provides an overview of a complete, end-to-end oligonucleotide workflow solutions

MS1 Oligonucleotide Characterization Using LC/Q-TOF with HILIC Chromatography

In this application note, LC separation and MS1 mass identification of a variety of oligos without the use of ion‑pairing reagents is demonstrated. The LC separation allows subsequent positive mode use with little to no flushing or hardware changes. This HILIC-based method uses an Agilent InfintyLab Poroshell 120 HILIC-Z column and MS-friendly ammonium acetate-based mobile phases. The samples were analyzed on an Agilent 1290 Infinity II LC system and a 6545XT AdvanceBio quadrupole time-of-flight mass spectrometer (LC/Q-TOF).

Oligonucleotide Characterization by Agilent 1290 Infinity II Bio LC and 6545XT AdvanceBio LC/Q-TOF

Characterization of oligonucleotides requires robust analytical instrumentation and methods as well as ease-of-use data analysis tools. Biocompatibility mitigates non-specific sample binding to flow path and it ensures the integrity of biomolecules and robustness of the system. In this study, two workflows, the Target Plus Impurities (TPI) and Sequence Confirmation workflows in Agilent MassHunter BioConfirm software, were carried out to characterize two oligonucleotide samples.